POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Philippines declares national dengue epidemic, 622 dead

Christian Fernsby |
The Philippines declared a national dengue epidemic on Tuesday after hundreds of people died of the disease this year.

Article continues below




There were 146,062 cases of dengue from Jan 1 to Jul 20 this year, the Department of Health (DOH) said, a 98 per cent increase from the same period the previous year. A total of 622 people have died from dengue, Health Secretary Francisco Duque told a news conference.

The country also stood firm on its ban on the world's first dengue vaccine Dengvaxia, which was banned following the deaths of dozens of children who were among more than 700,000 people given shots in 2016 and 2017 in a government immunisation campaign.

Duque said the government is studying an appeal to allow French pharmaceutical firm Sanofi to put the vaccine back in the Philippine market, but ruled out using the drug to combat the ongoing epidemic.

"This vaccine does not squarely address the most vulnerable group which is the five to nine years of age," Duque said.

The vaccine, now licensed in 20 countries according to the World Health Organization, is approved for use for those aged nine and older.


What to read next

Dengue fever, a resurging tropical disease
Antibody protects against Zika and dengue
One step closer to halting spread of Zika, dengue, chikungunya